Characteristics and Prognosis of Patients With Fibromuscular Dysplasia in a Population of Spontaneous Coronary Artery Dissections (from the French Registry of Spontaneous Coronary Artery Dissections "DISCO").


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
15 07 2022
Historique:
received: 28 12 2021
revised: 22 03 2022
accepted: 05 04 2022
pubmed: 14 5 2022
medline: 16 6 2022
entrez: 13 5 2022
Statut: ppublish

Résumé

Spontaneous coronary artery dissection (SCAD) and fibromuscular dysplasia (FMD) are pathologies that appear to be closely related. This study compares the characteristics of the FMD population to the non-FMD population in a SCAD cohort. It thus assesses the involvement of the FMD phenotype in a SCAD population. From the data of the French DISCO registry, we included patients with a diagnosis of SCAD and in whom a search for FMD was performed. We collected the following characteristics of this population: the clinical and angiographic presentation, the data concerning the management, and the events occurring during the follow-up. In the 373 SCADs confirmed in the DISCO registry, we obtained imaging data for 340 of them. FMD was found in 45% of cases. The mean age was higher in the FMD group, 53.2 ± 8.8 years, versus 50.1 ± 11 years in the non-FMD group. High blood pressure and postmenopausal status were significantly higher in the FMD group. Clinical presentation, angiographic data, and management were comparable. The major adverse cardiac event rate and recurrence rate were not different between the 2 groups after 1 year of follow-up. In conclusion, we confirmed a 45% prevalence of FMD in the SCAD population. The median age was higher in the FMD group, suggesting that FMD may develop over time. The rate of major adverse cardiac events and recurrence were similar in the FMD group versus the non-FMD group after 1 year of follow-up.

Identifiants

pubmed: 35562298
pii: S0002-9149(22)00401-5
doi: 10.1016/j.amjcard.2022.04.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

38-43

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosures The authors have no conflicts of interest to declare.

Auteurs

Nicolas Combaret (N)

Department of Cardiology, Clermont-Ferrand University Hospital Center, Centre National de la Recherche Scientifique, Clermont Auvergne University, Clermont-Ferrand, France. Electronic address: n_combaret@chu-clermontferrand.fr.

Quentin Liabot (Q)

Department of Cardiology, Clermont-Ferrand University Hospital Center, Centre National de la Recherche Scientifique, Clermont Auvergne University, Clermont-Ferrand, France.

Mays Deiri (M)

Department of Radiology, Clermont-Ferrand University Hospital Center, Centre National de la Recherche Scientifique, Clermont Auvergne University, Clermont-Ferrand, France.

Thibault Lhermusier (T)

Department of Cardiology, University Hospital of Rangueil, Toulouse, France.

Emmanuel Boiffard (E)

Department of Cardiology, Vendée Hospital center, La Roche-sur-Yon, France.

Emmanuelle Filippi (E)

Department of Cardiology, General Hospital of Atlantic Brittany, Vannes, France.

Vincent Roule (V)

Department of Cardiology, Caen University Hospital, Caen, France.

Jean-Louis Georges (JL)

Department of Cardiology, Centre Hospitalier de Versailles, Le Chesnay-Rocquencourt, France.

Stéphane Manzo-Silberman (S)

Department of Cardiology, Lariboisière Hospital Paris University, Paris, France.

Arnaud Fluttaz (A)

Department of Cardiology, Centre Hospitalier Metropole Savoie, Chambery, France.

Stéphanie Marliere (S)

Department of Cardiology, Grenoble University Hospital, Grenoble, France.

Géraud Souteyrand (G)

Department of Cardiology, Clermont-Ferrand University Hospital Center, Centre National de la Recherche Scientifique, Clermont Auvergne University, Clermont-Ferrand, France.

Bruno Pereira (B)

Biostatistics Unit (Direction de la Recherche Clinique et de l'Innovation DRCI), Clermont-Ferrand University Hospital Center, Centre National de la Recherche Scientifique, Clermont Auvergne University, Clermont-Ferrand, France.

Lucie Cassagnes (L)

Department of Radiology, Clermont-Ferrand University Hospital Center, Centre National de la Recherche Scientifique, Clermont Auvergne University, Clermont-Ferrand, France.

Pascal Motreff (P)

Department of Cardiology, Clermont-Ferrand University Hospital Center, Centre National de la Recherche Scientifique, Clermont Auvergne University, Clermont-Ferrand, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH